Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,761.10
-21.50 (-1.21%)
Oct 23, 2026, 11:20 AM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 334.05 billion as of October 22, 2026. It is the 4,549th most valuable company in the world and the 256th biggest in India. Its market cap has increased by 26.50% in one year.
Market Cap
334.05B
Enterprise Value
348.05B
Revenue
96.83B
Global Rank
Country Rank
#256 India
PE Ratio
33.01
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 334.05B, an increase of 30.00%. That is a compound annual growth rate of 12.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 334.05B | 29.14% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 627.61B |
| Alkem Laboratories | 597.94B |
| Gland Pharma | 491.07B |
| Ipca Laboratories | 459.53B |
| Ajanta Pharma | 410.80B |
| Wockhardt | 311.03B |
| Piramal Pharma | 260.58B |
| Cohance Lifesciences | 175.55B |